The U.S. Opioids market is primarily driven by the increasing prevalence of chronic pain conditions such as arthritis, cancer, back pain, and lupus among others.
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |